Calypte Only Company with Full Menu of Tests.

finance.yahoo.com/q/pr?s=hiv


CORPORATE GOVERNANCE  
Calypte Biomedical Corp's Corporate Governance Quotient (CGQ®) as of 1-Aug-05 is better than 92.7% of CGQ Universe companies and 82.9% of Pharmaceuticals & Biotechnology companies.
 

steht doch da...

stock-report

die Empfehlung aus #1272+1273 stammt NICHT von mir ! Schon gemerkt ?!

Woher nimmst Du dir ständig das Recht mich als Pusher usw. zu bezeichnen ?! Schließlich poste ich hier nicht so n permanenten Schwachsinn wie Du !

Support/Resistance
Type Value Conf.
resist. 0.32 4
resist. 0.28 2
resist. 0.27 10
resist. 0.23 15
resist. 0.22 8
resist. 0.21 10
resist. 0.20 35
resist. 0.18 12
resist. 0.17 4
resist. 0.16 2
resist. 0.15 9
resist. 0.14 3
supp 0.13 7


über die 0,18$, max 0,20$ kommt ihr nicht hinaus...

bin gerade gekommen , habe mir Jack D. Schrank genommen und bin gerade am trinken.

China, China wir kommen , das wird ein Frohes Fest zu Weihnachten ; )


Im übrigens Aware U ist doch nicht so schlecht, immerhin wir sind leader im U Seg.

Gruß

C.O

Motocyclisme), the governing body for international motorcycle racing. Dr. Leatt
added, " I have personally worked with many professional scientists and racers
over the last three years and, as an off-road and road motorcycle racer myself,
I have spent countless hours in the field and at race tracks treating injuries.
I have also spent a great deal of time exhaustively examining injury reports
received by MSA, and other sources from all over the world, that involved
helmeted motor sports individuals. Using this data and mechanisms of injury, as
quoted in medical literature, I have designed a neck protection system that is
both relevant to competitors and based on medical research. I believe that there
is currently no similar neck protection system available that can offer the same
level of protection as the Leatt-Brace.

Investors should continue to monitor the progress of Leatt Corporation for
further developments! The Leatt Corporation is the exclusive global distributor
of the Leatt-Brace, a Prophylactic Neck Brace designed to prevent potentially
devastating motor sport injuries to the cervical spine (neck). Thousands of
dollars and many hours have been spent testing my designs in state-of-the-art
laboratories, like those at the Eurotype Test Center located at the South
African Bureau of Standards (SABS, www.dti.gov.za/thedti/sabs.htm), and
in the real world on numerous driver's shoulders, such as, Deon Joubert, three
time SA Supercar Champion and Dewald van der Berg, South African motor cross
champion.

For updated in-depth coverage and a company profile of Leatt Corporation, visit
www.backissuesofnewsalerts.us/LEAT0906.html The stock closed yesterday at
Seventy Nine cents a share.

In case you are not familiar with the company: The Leatt Corporation is in the
business of designing, developing and manufacturing cervical spine (neck)
protection equipment for all forms of motor sports. The inventor of the brace,
Dr. Chris Leatt, is the President of The Leatt Corporation Inc., and is
responsible for executing the company's global strategy. The main area of focus
is the prevention of neck injuries in persons wearing a crash helmet, for
whatever purpose. The impetus for the project came from Dr. Chris Leatt's
medical knowledge, his history as a motorcycle racer and the many neck injuries
he has witnessed. The product not only has motor sport applications, but the
Company believes that it can be used by anyone wearing a crash helmet as a form
of protection. The company's website is www.leatt-brace.com.

Stocks showing interesting activity yesterday at the close of the regular
trading day were: Lifecore Biomedical, Inc. (NASDAQ: LCBM) up 2% on 75,305
shares traded, General Motors Corp. (NYSE: GM) up 0.5% on 5.1 million shares
traded, Elan Corporation, plc (NYSE: ELN) down 1.9% on 4.2 million shares traded
and Calypte Biomedical Corporation (AMEX: HIV) up 28.5% on 3.9 million shares
traded.

Commentary: " In the economic sector the ISM, Institute of Supply Managers,
reported that for August their index was up 65.0 from the previous month of
60.5, the best in 12 months. New orders, employment, and inventories were all up
stimulating the economy," Stated Sonja Rudd in Wall Street News Alert's daily
commentary continued at: www.WallStreetNewsAlert.com.

Let Wall Street News Alert help advertise for your company using our effective
awareness campaigns. If you're Interested in telling your story, we can help.
Contact us at info@wallstreetnewsalert.com

WSNA's email alert service is free to those investors who sign up on the WSNA
home page. The alert service is designed to notify investors of undervalued and
often overlooked stocks. Subscribers are introduced to Special Situation
companies that have the potential of showing increased activity. The Wall Street
News Alert home page has experienced over 50 million hits. To subscribe to this
free service, visit the Wall Street News Alert home page at
www.wallstreetnewsalert.com and select the " join now" button
*** Wall Street News Alert is not affiliated with faxes bearing names such as:
Wall Street Stock Alert, Wall Street Investor Alert, Wall Street News Alert or
any other fax using various combinations of the generic words Wall Street! If
you receive any such fax, please do not contact us at
www.wallstreetnewsalert.com. You may wish to inquire about the fax, with the CEO
of the company that the fax is written about ***

Wall Street News Alert is a division of Wall Street Capital Funding LLC (WSCF).
WSCF is not a registered broker/dealer and may not sell, offer to sell or offer
to buy any security. WSCF profiles are not a solicitation or recommendation to
buy, sell or hold securities. An offer to buy or sell can be made only with
accompanying disclosure documents from the company offering or selling
securities and only in the states and provinces for which they are approved. The
material in this release is intended to be strictly informational. The companies
that are discussed in this release have not approved the statements made in this
release nor approved the timing of this release. All statements and expressions
are the sole opinion of WSCF and are subject to change without notice.
Information in this release is derived from a variety of sources including that
company's publicly disseminated information, third parties and WSCF research.
The accuracy or completeness of the information is not warranted and is only as
reliable as the sources from which it was obtained. WSCF disclaims any and all
liability as to the completeness or accuracy of the information contained and
any omissions of material fact in this release. The release may contain
technical inaccuracies or typographical errors. It is strongly recommended that
any purchase or sale decision be discussed with a financial adviser, or a
broker-dealer, or a member of any financial regulatory bodies. Investment in the
securities of the companies' discussed in this release is highly speculative and
carries a high degree of risk. WSCF is not liable for any investment decisions
by its readers or subscribers. Investors are cautioned that they may lose all or
a portion of their investment if they make a purchase in WSCF profiled stocks.

This profile is not without bias, and is a paid release. WSCF has been
compensated for dissemination of company information on behalf of one or more of
the companies mentioned in this release. (WSCF has been compensated Twelve
Thousand Dollars for coverage of Leatt Corporation (OTC: LEAT), by the company,
for services provided including dissemination of company information in this
release. WSCF holds no shares of the stock. WSCF may receive shares or cash for
extension of its services. Any shares will be disclosed at such time that WSCF
is aware of a clients desire to extend the original services. WSCF may have
received shares of a company profiled in this release prior to the dissemination
of the information in this release. WSCF may immediately sell some or any shares
in a profiled company held by WSCF and may have previously sold shares in a
profiled company held by WSCF. WSCF's services for a company may cause the
company's stock price to increase, in which event WSCF would make a profit when
it sells its stock in a company. In addition, WSCF's selling of a company's
stock may have a negative effect on the market price of the stock.

This release contains " forward-looking statements" within the meaning of Section
27A of the Securities Act of 1933, as amended, and Section 21E the Securities
Exchange Act of 1934, as amended and such forward-looking statements are made
pursuant to the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995. " Forward-looking statements" describe future expectations,
plans, results, or strategies and are generally preceded by words such as " may" ,
" future" , " plan" or " planned" , " will" or " should" , " expected," " anticipates" ,
" draft" , " eventually" or " projected" . You are cautioned that such statements are
subject to a multitude of risks and uncertainties that could cause future
circumstances, events, or results to differ materially from those projected in
the forward-looking statements, including the risks that actual results may
differ materially from those projected in the forward-looking statements as a
result of various factors, and other risks identified in a companies' annual
report on Form 10-K or 10-KSB and other filings made by such company with the
Securities and Exchange Commission. You should consider these factors in
evaluating the forward-looking statements included herein, and not place undue
reliance on such statements. The forward-looking statements in this release are
made as of the date hereof and WSCF undertakes no obligation to update such
statements.

CONTACT: Wall Street News Alert e-mail: info@wallstreetnewsalert.com WWW:
www.wallstreetnewsalert.com

M2 Communications Ltd disclaims all liability for information provided within M2
PressWIRE. Data supplied by named party/parties. Further information on M2
PressWIRE can be obtained at www.presswire.net on the world wide web Inquiries to info@m2.com.




(C)1994-2005 M2 COMMUNICATIONS LTD

**************************************************

As of Saturday, 09-03-2005 23:59, the latest Comtex SmarTrend(SM) Alert,
an automated pattern recognition system, indicated an UPTREND on
08-09-2005 for ELN @ $9.24.

As of Saturday, 09-03-2005 23:59, the latest Comtex SmarTrend(SM) Alert,
an automated pattern recognition system, indicated a DOWNTREND on
08-05-2005 for GM @ $35.81.

As of Saturday, 09-03-2005 23:59, the latest Comtex SmarTrend(SM) Alert,
an automated pattern recognition system, indicated a DOWNTREND on
08-11-2005 for LCBM @ $11.19.

(C) 2005 Comtex News Network, Inc. All rights reserved.


performaxx Research: Neues Research: Barnabus Energy – Kaufen!!

dich in ärztliche Behandlung zu begeben. Am Anfang dachte ich, du wärest echt nur jemand, der eine Meinung vertritt, zwar mit etwas rabiaten Methoden, aber jedem das seine. Nach den letzten Tagen und gerade nach deinen letzten Postings muß ich diese Meinung revidieren. Du wirst den Leuten so nicht zeigen, wie sch... Caly doch ist, sondern du zeigst ihnen einen kranken, einsamen und völlig vergifteten Menschen, der sich hier eine Lebensaufgabe geschaffen hat. Gehst du noch raus?. Du tust mir gerade wirklich leid. Lies dir mal deine haßerfüllten Kommentare durch. Du bist hier an der Börse und nicht in einem Roman von Stephen King oder Hitchcock. Aber was sage ich. Du hast dich mittlerweile so hierrein gesteigert, das jedes Wort, jede Antwort umsonst ist. Du schreibst auch in drei Jahren noch....alleine, dich mit dir selbst unterhaltend. Armer Kerl. Hol dir Hilfe, bevor es zu spät ist und du (wenn es nicht schon geschehen ist) den Sinn für die Realität verlierst, denn du denkst nicht mehr rational, sondern persönlich. Auf jeden Fall hast du schon Verfolgungswahn. Das wurde mir von jemandem, der auf diesem Gebiet Kenntnisse besitzt, bestätigt und dieser jemand hat noch nicht einmal Ahnung von Aktien. Mittlerweile bist du schon ein Thema in anderen Foren und diese solltest du mal ausfindig machen, um mal Reaktionen von Unbeteiligten zu dir zu erfahren. Ich denke, du wärest schockiert.....NEIN, zurück.....das wären dann auch alles Leute, die Kade, Broker und uns hörig sind. Ich vergaß.... Wir sind eine Sekte und die Mods hängen auch mit drin...... Hol dir Hilfe Junge!!!!  

vor gut 1 1/2 Jahren gesagt das er Fach-Ärztliche Hilfe braucht *g*





Gruß

C.O

zum start!! caly wird sicher in richtung 0.25$ laufen!
bin noch nicht dabei, steige heute aber ev. ein!
hoffe es ist nicht zu spät.... mal seh'n!!

hat gerade einer 215.3k gekauft....

Position- Long; ST Rating- Strong Buy; LT Rating- Strong Buy

View: Annual Data | Quarterly Data All numbers in thousands
PERIOD ENDING 30-Jun-05 31-Mar-05 31-Dec-04 30-Sep-04
Total Revenue 794   665   1,055   361  
Cost of Revenue 1,766   1,520   2,190   2,095  

Gross Profit (972) (855) (1,135) (1,734)

Operating Expenses
Research Development 710   762   517   509  
Selling General and Administrative 2,046   1,414   2,443   1,800  
Non Recurring -   -   -   -  
Others -   -   -   -  
 
Total Operating Expenses -   -   -   -  


Operating Income or Loss (3,728) (3,031) (4,095) (4,043)

Income from Continuing Operations
Total Other Income/Expenses Net 1,754   (27) (25) 6  
Earnings Before Interest And Taxes (1,974) (3,058) (4,466) (3,881)
Interest Expense (260) 260   1,713   (79)
Income Before Tax (1,714) (3,318) (6,179) (3,802)
Income Tax Expense 2   -   -   -  
Minority Interest -   -   (346) 156  
 
Net Income From Continuing Ops (1,716) (3,318) (6,179) (3,802)

Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  


Net Income (1,716) (3,318) (6,179) (3,802)
Preferred Stock And Other Adjustments -   -   -   -  

Net Income Applicable To Common Shares ($1,716) ($3,318) ($6,179) ($3,802)

CALYPTE BIOMEDICAL (RT-ECN)    
Symbol: HIV
Last Trade: 0.20 10:10AM ET
After Hours Change: N/A
Today's Change:  0.02 (11.11%)
Bid: 0.15
Ask: 0.21